Researchers have developed a new way to study how biochemical processes can impair the immune system’s ability to recognize ...

Uganda is collaborating with researchers from the United States to develop treatments for cancer and diabetes. Uganda’s President Yoweri Kaguta Museveni announced that he welcomed a team of American ...

Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...

The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...

Scientists have decoded a century-old killer hiding in a preserved lung. New genetic evidence from 1918 reveals the virus was ...

Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, emerges from stealth today and announces that the U.S. Food and Drug Administration ...

Certain types of biochemical processes can impair the immune system’s ability to recognize and kill cancer cells. Purdue ...

A recent study developed a highly accurate risk prediction framework for preterm birth (PTB) that could broaden the potential ...

From Johns Hopkins University School of Medicine, Charlotte J. Sumner, M.D., presents an editorial on a study by Richard S.